Skip to main content

Recruiting the microcirculation in septic shock

  • The Correction to this article has been published in Annals of Intensive Care 2019 9:107

Mortality of critically ill patients is driven by severity of the insult, comorbidities, appropriate treatment, and organ failure. The pathophysiological mechanisms leading to organ failure during sepsis remain poorly understood. The direct toxicity of pro-inflammatory mediators and/or bacterial components and/or circulating particles released from damaged cells has been suggested to contribute to organ dysfunction. Alterations of microcirculatory perfusion were associated with organ failure severity and mortality in septic shock patients. Tissue perfusion is likely to play a role in the development of organ dysfunction either due to systemic or regional alterations. Interestingly, organ dysfunction may persist despite apparent restoration of systemic macrohemodynamic variables [1]. Optimal macrohemodynamic targets to perfuse and recruit the microvessels may vary, however, between patients and between vascular beds [2].

Altogether, these associations suggest that intra-organ blood flow defects might be (at least partially) causal in the development of organ failure and targeting the microcirculation might promote organ recovery and better outcome. The question of which therapeutics may be implemented based on peripheral perfusion or microcirculation assessment is central. While animal studies have shown a beneficial impact of treatment targeting the microcirculation on organ blood flow and damage recovery, clinical data are scarcer [3]. Therapeutic intervention can help improving organ perfusion in selected patients. Fluid loading was shown to improve microcirculatory blood flow when applied early on during the course of sepsis [4] or in the operating room [5]. Dobutamine improved microvascular perfusion in some patients but not in others [6]. In post-cardiopulmonary bypass shock, increasing the perfusion pressure (PP) by increasing the mean arterial pressure (MAP) from 60 to 75 mmHg using norepinephrine could increase renal blood flow and glomerular filtration rate. Variability in the best PP for optimizing renal blood flow, however, further underlined the variability in response to treatments. Some patients did improve their renal hemodynamic while other deteriorated while further increasing MAP from 75 to 90 mmHg [7]. Others showed that increasing the MAP above 65 mmHg did not improve microperfusion or even could worsen it in some patients [8,9,10]. A vasopressor challenge in patients with multiple organ failure remaining hypoperfused despite fluids (i.e. oliguria, increased capillary refilling time, mottling, cold extremities) can work out the best perfusion pressure to recruit microvessels. Monitoring the perfusion response to an increase of PP is, however, warranted to avoid overtreatment in unresponsive patients. Transfusion of red blood cells can increase the microcirculatory flow and the proportion of perfused vessels after an haemorrhagic shock [11] or in some but not all septic patients with anaemia [12]. In any case, a wide variability exists between patients regarding the impact of fluids and vasopressors to recruit the microcirculation. The benefit of improving cardiac output and increasing MAP on the microcirculation appear prominent when these parameters and the capillary perfusion are altered at baseline before the therapeutic challenge. Yet imaging monitoring tools (i.e. side-dark field imaging) have revealed that microcirculatory disorders may persist despite the apparent normalization of macrohemodynamic variables.

Among the mechanisms implicated in the impairment of microcirculatory blood flow (i.e. intravascular thrombosis, endothelial dysfunction, increased extravascular tissue pressure), altered balance between levels of vasoconstrictive and vasodilating substances may be sensitive to vasodilatory agents [13]. An important study from De Backer et al. highlighted that topical administration of acetylcholine, a powerful endothelium-dependent vasodilating agent, restored the sublingual microcirculatory blood flow in septic shock patients suggesting a role for vasodilating agents [14]. In an animal model, administration of l-arginine could restore the microcirculation when combined with vasopressors during endotoxemia [15]. These findings suggest that inappropriate vasoconstriction may be central in the sepsis-associated microperfusion reduction and this could be totally reversed, opening an area for vasodilator-based therapeutic intervention.

Whether intravascular administration of vasodilator agents acting at the resistive arterioles may improve capillary blood flow remains to be determined (Fig. 1) [16]. We propose to illustrate the intense heterogenous vasoconstriction of resistive arterioles, associated with a drop of the critical closing pressure in some territories as the “bottleneck-like vascular barrier” (Fig. 1). This theory may therefore reconcile the con-intuitive approach of providing both vasopressors and vasodilators in distributive shock. Selecting the best vasodilating drug and the best population that could benefit from vasodilating drug are major issues. De Backer et al. showed that dobutamine could recruit the microcirculation in septic patients, independently of the cardiac response, through its vasodilating action [6, 17]. In a randomized study including 70 septic shock patients, nitroglycerin did not provide any benefit at the microcirculation level and tend to worsen prognosis [18]. However, nitroglycerin yields significant venous dilatory properties. In addition the trial mostly included patients with uncompromised sublingual microcirculatory blood flow so that the improvement in microcirculation was expected to be very limited. Prostacyclin analogues are potent arteriolar vasodilators that may fulfil the criteria of predominantly acting at the precapillary level. Experimental data suggest that prostacyclin derivatives may improve microvascular perfusion [19]. Prostacyclin analogue administration has shown promising results in shock patients [20] and is currently investigated in a multicentre randomized controlled trial (NCT03788837).

Fig. 1

Schematic representation of microvascular recruitment strategies of microvessels in distributive shock. Impaired tissue perfusion in distributive shock may be associated with low arterial pressure due to systemic vasodilation and intense vasoconstriction of precapillaries arterioles and external compression of capillaries in some vascular territories (Panel 1). Vasopressor agents increase inflow pressure by arteriolar vasoconstriction. Cardiac output can also increase due to venous constriction. Perfusion pressure may not increase despite the arterial pressure rise if the increase in perfusion pressure is insufficient to overcome precapillary vascular resistance and its closing critical pressure (Panel 2). This obstruction—theorized as a vascular bottleneck—might be targeted using vasodilators, which may improve microcirculatory flow and oxygen supply in selected patients (Panel 3)

Selecting the right patients for the right treatments in a tailored microcirculatory-targeting strategy will be mandatory. At the bedside, skin mottling around the knee area, prolonged capillary refill time, central-to-peripheral gradient temperature are the easily and frequently observed manifestations of microperfusion disorders [21]. These clinical parameters correlated with organ failure severity and are predictive of ICU mortality and may help guiding the treatment. A recent large-scale trial demonstrated that capillary refill time can be used to guide early resuscitation [22]. However, the resuscitations measures were mostly oriented toward the systemic circulation. Future well-designed investigations should answer the question whether strategies aimed at recruiting the microcirculation may be triggered by these variables and may improve outcome. Yet, these clinical signs might fail to explore the heterogeneity of microperfusion between vascular beds and organs but also inside some organs. Selecting the patients with a profoundly altered microcirculation unresponsive to conventional therapy is crucial. “Easy to use, easy to learn” clinical signs are available and can identify patients with severe peripheral tissue hypoperfusion. Such investigations will answer the question whether we should target the “microcirculation bottleneck” in shock patients.

Availability of data and materials

Not applicable.

Change history

  • 24 September 2019

    After publication of the original article [1], we were notified that an author’s name has been incorrectly spelled. Author’s first name is Hafid and the family name is Ait-Oufella (with a hyphen between Ait and Oufella). The original article has been corrected.


  1. 1.

    De Backer D, Cecconi M, Lipman J, Machado F, Myatra SN, Ostermann M, et al. Challenges in the management of septic shock: a narrative review. Intensive Care Med. 2019;45(4):420–33.

    Article  Google Scholar 

  2. 2.

    Ince C, Boerma EC, Cecconi M, De Backer D, Shapiro NI, Duranteau J, et al. Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2018;44:281–99.

    Article  Google Scholar 

  3. 3.

    Le Dorze M, Legrand M, Payen D, Ince C. The role of the microcirculation in acute kidney injury. Curr Opin Crit Care. 2009;15:503–8.

    Article  Google Scholar 

  4. 4.

    Ospina-Tascon G, Neves AP, Occhipinti G, Donadello K, Büchele G, Simion D, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010;36:949–55.

    Article  Google Scholar 

  5. 5.

    Bouattour K, Teboul J-L, Varin L, Vicaut E, Duranteau J. Preload dependence is associated with reduced sublingual microcirculation during major abdominal surgery. Anesthesiology. 2019;130:541–9.

    Article  Google Scholar 

  6. 6.

    De Backer D, Creteur J, Dubois M-J, Sakr Y, Koch M, Verdant C, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med. 2006;34:403–8.

    Article  Google Scholar 

  7. 7.

    Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten S-E. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med. 2011;37:60–7.

    CAS  Article  Google Scholar 

  8. 8.

    Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Accessed 12 July 2019.

  9. 9.

    LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729–32.

    CAS  Article  Google Scholar 

  10. 10.

    Dubin A, Pozo MO, Casabella CA, Pálizas F, Murias G, Moseinco MC, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care Lond Engl. 2009;13:R92.

    Article  Google Scholar 

  11. 11.

    Tanaka S, Escudier E, Hamada S, Harrois A, Leblanc PE, Vicaut E, et al. Effect of RBC transfusion on sublingual microcirculation in hemorrhagic shock patients: a pilot study. Crit Care Med. 2017;45:e154–60.

    Article  Google Scholar 

  12. 12.

    Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois M-J, Koch M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med. 2007;35:1639–44.

    Article  Google Scholar 

  13. 13.

    Skytte Larsson J, Krumbholz V, Enskog A, Bragadottir G, Redfors B, Ricksten S-E. Renal blood flow, glomerular filtration rate, and renal oxygenation in early clinical septic shock. Crit Care Med. 2018;46:e560–6.

    Article  Google Scholar 

  14. 14.

    De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98–104.

    Article  Google Scholar 

  15. 15.

    Nakajima Y, Baudry N, Duranteau J, Vicaut E. Effects of vasopressin, norepinephrine, and l-arginine on intestinal microcirculation in endotoxemia. Crit Care Med. 2006;34:1752–7.

    CAS  Article  Google Scholar 

  16. 16.

    Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, et al. The human microcirculation: regulation of flow and beyond. Circ Res. 2016;118:157–72.

    CAS  Article  Google Scholar 

  17. 17.

    Ospina-Tascón GA, García Marin AF, Echeverri GJ, Bermudez WF, Madriñán-Navia H, Valencia JD, et al. Effects of dobutamine on intestinal microvascular blood flow heterogeneity and O2 extraction during septic shock. J Appl Physiol Bethesda Md. 1985;2017(122):1406–17.

    Google Scholar 

  18. 18.

    Boerma EC, Koopmans M, Konijn A, Kaiferova K, Bakker AJ, van Roon EN, et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med. 2010;38:93–100.

    CAS  Article  Google Scholar 

  19. 19.

    Johannes T, Ince C, Klingel K, Unertl KE, Mik EG. Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat. Crit Care Med. 2009;37:1423–32.

    CAS  Article  Google Scholar 

  20. 20.

    Dépret F, Sitbon A, Soussi S, De Tymowski C, Blet A, Fratani A, et al. Intravenous iloprost to recruit the microcirculation in septic shock patients? Intensive Care Med. 2018;44:121–2.

    Article  Google Scholar 

  21. 21.

    Hariri G, Joffre J, Leblanc G, Bonsey M, Lavillegrand J-R, Urbina T, et al. Narrative review: clinical assessment of peripheral tissue perfusion in septic shock. Ann Intensive Care. 2019;9:37.

    Article  Google Scholar 

  22. 22.

    Hernández G, Ospina-Tascón GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-Day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654–64.

    Article  Google Scholar 

Download references


Not applicable.

Author information




ML, DdB, FD, HA-O drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Matthieu Legrand.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: we were notified that an author’s name has been incorrectly spelled. Author’s first name is Hafid and the family name is Ait-Oufella (with a dash between Ait and Oufella)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Legrand, M., De Backer, D., Dépret, F. et al. Recruiting the microcirculation in septic shock. Ann. Intensive Care 9, 102 (2019).

Download citation